Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: C09DB01

Amlodipine / Valsartan Mylan(amlodipine besilate;valsartan)

Hypertension

Marketing Authorisation Holder: Mylan Pharmaceuticals Limited

EMA Authorisation: 22/03/2016

INN: amlodipine;valsartan

Indication

Treatment of essential hypertension. Amlodipine/Valsartan Mylan is indicated in adults whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Amlodipine / Valsartan Mylan — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.